By Debdeep Gupta | 24 Apr, 2026
Sun Pharma moves ahead with $13 billion Organon bid amid global expansion push: Report
Dilip Shanghvi is moving ahead with what could become his biggest deal yet, with a binding offer of nearly $13 billion submitted for US-based Organon & Co, an Economic Times report said on Friday. The proposed acquisition is part of Sun Pharmaceutical Industries' broader push to evolve from an Indian generics leader into a global branded and innovation-driven drugmaker.Sun Pharma, India's largest ...


